DVL1P1
Summary:
| Name | OMIM ID | Ensembl ID | HGNC ID | PHARMGKB ID | Map Location |
|---|---|---|---|---|---|
| dishevelled segment polarity protein 1 pseudogene 1 | MIM:601225 | HGNC:HGNC:3085 | PA27541 | 22q11.21|22q11 |
GO terms in DVL1P1
| Term Type | Evidence Type | GO Term ID | GO Des. |
|---|
Gene expression in normal tissue: DVL1P1
Gene-model tissue-cancer distribution: Bubble Plot
Gene-drug pathway distribution
Pathways in DVL1P1
| Database | Pathway ID | Pathway Des. |
|---|
Gene-Drug: Aster Plot
| Drug ID | Drug Name | Model Num. |
|---|---|---|
| iGMDRD132 | (-)-gallocatechin-3-O-gallate | 3 |
| iGMDRD945 | ML214 | 3 |
| iGMDRD499 | PDMP | 5 |
| iGMDRD85 | Ursolic acid | 1 |
| iGMDRD512 | nutlin 3 | 1 |
| iGMDRD307 | Manumycin A | 3 |
| iGMDRD84 | Lovastatin acid | 2 |
| iGMDRD82 | Quiflapon | 3 |
| iGMDRD147 | Prima-1 | 1 |
| iGMDRD662 | JQ-1 | 3 |
| iGMDRD872 | BRD7137 | 3 |
| iGMDRD871 | BRD6368 | 3 |
| iGMDRD434 | BMS-536924 | 4 |
| iGMDRD221 | Tamoxifen | 3 |
| iGMDRD5 | Tyrphostin AG 1478 | 3 |
| iGMDRD202 | Curcumin | 3 |
| iGMDRD271 | Brefeldin A | 3 |
| iGMDRD466 | Chaetocin | 3 |
| iGMDRD61 | Kinetin riboside | 2 |
| iGMDRD670 | ML 210 | 3 |
| iGMDRD772 | BRD4770 | 5 |
| iGMDRD889 | Compound 7d-cis | 3 |
| iGMDRD126 | Tipifarnib | 2 |
| iGMDRD524 | ISX-9 | 3 |
| iGMDRD23 | Gossypol | 3 |
| iGMDRD398 | Sepantronium | 2 |
| iGMDRD577 | BIX01294 | 3 |
| iGMDRD887 | Compound 23 citrate | 4 |
| iGMDRD188 | Piperlongumine | 2 |
| iGMDRD100 | Zebularine | 2 |
| iGMDRD318 | PAC-1 | 3 |
| iGMDRD260 | FQI-2 | 1 |
Gene in drug-gene network: Network Plot
Gene-drug targets distribution
Gene Structure: PDB
Models in DVL1P1
CLASSFICATION
Copyright © 2018 Modellab | All Rights Reserved
Disclaimer: iGMDR is intended for research purposes only. Its information cannot be used for emergencies or medical or professional advice.